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The development of the fetal testis requires 
complex hormonal regulation and thus forms 
a highly sensitive detector for hormonal dis-
ruption (Sharpe 2006). Phthalate esters are 
known to be endocrine disruptors, chemi  cals 
that alter normal endocrine function and regu-
lation, in particular, during male sex deter-
mination and differentiation (Foster 2005; 
Henley and Korach 2006; Waring and Harris 
2005). Di-(2-ethylhexyl) phthalate (DEHP) 
is the most common chemical additive used 
in the manufacture of plastics and is conse-
quently distributed widely, for instance, in 
infant toys, cosmetics, food packaging, and 
medical devices [Agency for Toxic Substances 
and Disease Registry (ATSDR) 2002]. Because 
DEHP is not covalently bound to the poly-
mers, it leaches from the matrix and is endemic 
to the human environment (Hashizume et al. 
2002; Rudel et al. 2003), so humans are con-
stantly exposed to phthalates through oral, der-
mal, and inhalation routes (Koch et al. 2006; 
Wormuth et al. 2006). After exposure, DEHP 
is rapidly hydrolyzed by esterases in the gut, 
liver, and blood into mono-(2-ethylhexyl) 
phthalate (MEHP), which is believed to be the 
active molecule (Gray 1986). MEHP is then 
hydrolyzed to mono-(2-ethyl-5-hydroxyhexyl) 
phthalate (5OH-MEHP) and metabolized 
into mono-(2-ethyl-5-oxo  hexyl) phthalate 
(5OXO-MEHP) (Koch et al. 2003). MEHP is 
also ω-oxidized into mono-(2-ethyl-5-carboxy-
pentyl) phthalate (5CX-MEPP) (Koch et al. 
2005). The degree of in utero exposure has 
been demonstrated in humans when DEHP 
and MEHP were found in amniotic fluid, 
cord blood, and embryonic tissues (Latini et al. 
2003; Silva et al. 2004). Moreover, DEHP has 
been proposed to exert disrupting effects on 
male reproductive development in a prospec-
tive mother–son cohort investigation (Swan 
et al. 2005) and to alter a number of endocrine 
parameters in infants through breast-feeding 
(Main et al. 2006).
In animal models, experimental data have 
established phthalate toxicity on testicular 
function in prenatal, neonatal, and post  natal 
rats. Thus, pregnant rats exposed to DEHP or 
di-n-butyl phthalate gave birth to fetuses with 
reproductive tract defects such as hypospadias, 
decreased anogenital distance, retained nip-
ples, epididymal agenesis, malformed seminal 
vesicles, and cryptorchidism (Imajima et al. 
1997; Jiang et al. 2007; Rider et al. 2008; 
Shono et al. 2005). The great majority of 
these in vivo studies were conducted in utero 
and cannot distinguish between direct versus 
indirect effects via metabolites. In the present 
study, we assessed the direct effects of DEHP 
and its metabolites MEHP, 5OH-MEHP, 
5OXO-MEHP, and 5CX-MEPP on testis 
development using an organo  typic culture 
system previously established for the rat 
(Habert et al. 1991; Lassurguere et al. 2003). 
This in vitro system displays many develop-
mental events observed in vivo (Livera et al. 
2006) and supports the independent study of 
the dose- and time-related effects on somatic 
and germ cells of fetal testes.
Materials and Methods
Animals and sample collection. Pregnant 
female Sprague-Dawley rats from the indoor 
breeding colony of GERHM (Research Group 
on Human and Mammalian Reproduction)–
INSERM, U625, and from Elevage Janvier 
(Le Genest Saint-Isle, Laval, France) were 
anesthetized by intra  peritoneal injection of 
40 mg/kg sodium pento  barbital (Sanofi-
Synthélabo, Libourne, France) on gestation 
day 14.5 (GD14.5; day of mating was GD0) 
according to the French ethics committee of 
the University of Rennes I. The testes were 
aseptically removed from the fetuses under 
a binocular microscope and then immedi-
ately explanted in vitro. All animals were kept 
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Ba c k g r o u n d: Endocrine-disrupting effects of phthalates are understood primarily from in utero 
exposures within the fetal rat testis. Nevertheless, their path of action, dose–response character, and 
cellular target(s) within the fetal testis are not known.
oBjectives: In this study we investigated the effects of di-(2-ethylhexyl) phthalate (DEHP), mono-
(2-ethylhexyl) phthalate (MEHP), and several of their metabolites on the development of organo-
cultured testes from rat fetus.
Me t h o d s : We removed testes from 14.5-day-old rat fetuses and cultured them for 1–3 days with or 
without DEHP, MEHP, and the metabolites.
re s u l t s: DEHP (10–5 M) produced a proandrogenic effect after 3 days of culture, whereas MEHP 
disrupted testis morphology and function. Leydig cells were the first affected by MEHP, with a 
number of them being inappropriately located within some seminiferous tubules. Additionally, we 
found a time- and dose-dependent reduction of testosterone. By 48 hr, gonocyte proliferation had 
decreased, whereas apoptosis increased. Sertoli cell number was unaffected, although some cells 
appeared vacuolated, and production of anti-Müllerian hormone decreased in a time- and dose-
dependent manner. The derived metabolite mono-(2-ethyl-5-hydroxyhexyl) phthalate was the only 
one to cause deleterious effects to the rat fetal testis in vitro.
co n c l u s i o n: We hope that this in vitro method will facilitate the study of different phthalate esters 
and other endocrine disruptors for direct testicular effects.
key w o r d s : androgens, anti-Müllerian hormone, endocrine disruption, explant culture, fetal testis, 
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under standard housing conditions and were 
treated humanely and with regard for allevia-
tion of suffering.
Culture procedure. Testes were cultured 
on 0.45 µm Millipore filters (Millipore Corp., 
Bedford, MA, USA) as previously described 
(Habert et al. 1991; Lassurguere et al. 2003). 
Briefly, each GD14.5 fetal testis was removed 
with the adjacent meso  nephros, placed on a 
filter floating on 0.5 mL Gibco M199 medium 
(Invitrogen, Eragny sur Oise, France) sup-
plemented with 50 µg/mL gentamicin (Life 
Technologies, Cergy-Pontoise, France) and 
2.5 µg/mL Fungizone (Life Technologies) in 
culture dishes, and incubated in a humidified 
atmosphere (5% CO2 at 37°C) for 24, 48, or 
72 hr. One testis from each embryo was cul-
tured with medium containing 0.1% DMSO 
(Prolabo, Fontenay-sous-Bois, France) as the 
control and the other containing 10–4, 10–5, 
or 10–6 M DEHP (purity > 99%; Interchim, 
Montluçon, France) or MEHP (purity > 99%; 
Interchim) or 10–5 M 5OH-MEHP, 5OXO-
MEHP, or 5CX-MEPP (purity > 97%; the 
MEHP metabolites were prepared at the 
Institut und Poliklinik für Arbeits). All phtha-
lates were diluted in DMSO to a final concen-
tration of 0.1%. One-half of the volume of the 
culture medium was refreshed every 24 hr.
In a number of experiments, at the end 
of the culture period, we added 100 ng/
mL ovine leutinizing hormone (LH; NIH.
LH S19; 1.01 NIH.LH.S1 U/mg; gift from 
A.F. Parlow, National Institute of Diabetes 
and Digestive and Kidney Diseases, Bethesda, 
MD, USA) or 1 mM 5-bromo-2-deoxy  uridine 
(BrdU; Amersham, Buckinghamshire, UK) 
to the dishes in 500 µL of fresh medium for 
3 hr. Then, the whole explant was fixed for 
2 hr in 4% paraformaldehyde in phosphate-
buffered saline (PBS) at 4°C, washed in PBS, 
dehydrated, and embedded in paraffin. To 
estimate the concentration of the phthalate 
present within the fetal gonad, testes were 
incubated with 10–5 M radio  labeled phthalates 
following the same culture procedure described 
above. We used DEHP-ring-UL-14C (14C-
DEHP; 6.6 mCi/mmol; purity > 98%; Sigma-
Aldrich, Saint-Quentin-Fallavier, France) and 
14C-MEHP (2.2 mCi/mmol; provided by J.P. 
Cravedi, Institut National de la Recherche 
Agronomique, UMR 1089, Toulouse, France).
At the end of the culture, testes were 
separated from filters and both were digested 
in 1 mL Soluene-350 (PerkinElmer, 
Courtaboeuf, France) and then incubated at 
55°C (2 hr for the testes, overnight for the 
filters). The digested testes were dissolved 
in 10 mL Ultima Gold scintillating liquid 
(PerkinElmer), and radio  activity was counted 
using a Tricarb 2100 TR scintillation counter 
(PerkinElmer). These experi  ments allowed us 
to calculate that 0.3% of added DEHP and 
0.4% of added MEHP, both at 10–5 M, were 
present within the testes after 72 hr of culture. 
To assess the possible non  specific effects of the 
phthalates on the different cellular compart-
ments, we performed a thorough morphologic 
assessment of the gonads at the different time 
points of the culture and we directly counted 
the different cell types. Furthermore, to inves-
tigate the specificity of the effects of phthalates 
on testosterone production, we also tested the 
possible effects of 10–5 M and 10–4 M methyl 
palmitate (Sigma-Aldrich), which possesses 
the same lipo  philic properties as DEHP (Krop 
et al. 1997; Staples et al. 1997).
Identification of different cell types. To 
determine whether DEHP and MEHP caused 
histopathologic defects in rat fetuses, we 
immuno  stained the different testicular cell 
types using primary rabbit anti  bodies directed 
against DDX4/VASA (DEAD-box protein 4) 
for gonocytes (1:200; Abcam, Paris, France), 
3β-hydroxysteroid dehydrogenase (3β-HSD) 
for Leydig cells (1:500, provided by J.J. Feige, 
INSERM U878, Grenoble, France), and 
Wilms tumor gene protein 1 (WT-1; 1:500; 
Santa Cruz Biotechnology Inc., Santa Cruz, 
CA, USA) or anti-Müllerian hormone (AMH; 
1:1,000; provided by J.Y. Picard, INSERM 
U782, Clamart, France) for Sertoli cells. The 
embedded testes were serial sectioned trans-
versally at 5 µm. Deparaffinized sections 
were rehydrated, washed in PBS, heated for 
5 min in 0.01 M citrate buffer (pH 6.0), 
and incubated for 30 min in PBS with 1% 
bovine serum albumin as a blocking agent. 
The slides were incubated overnight at 4°C 
with the primary antibody, rinsed several 
times in PBS before 1 hr of treatment with a 
biotinylated goat anti-rabbit secondary anti-
body (DAKO, Trappes, France) followed by 
incubation for 30 min with an avidin-biotin-
peroxidase complex [streptavidin-horseradish 
peroxidase (HRP), 1:500; DAKO]. Staining 
was visualized with 3,3´-diaminobenzidine 
(DAB; DAKO) or a 3-amino-9-ethyl carba-
zole (AEC) chromogen kit (Beckman Coulter, 
Villepinte, France). The reaction was stopped 
by immersion in water; sections were then 
counterstained with hemalin and mounted.
Counting of cell types. We counted the 
immuno  positive cells using the Computer-
Assisted Stereology Toolbox (CAST) Grid 
System (Olympus, Copenhagen, Denmark) on 
a light microscope (Olympus BX S1). At first, 
we delineated the testis borders at low magnifi-
cation. Then, we counted the immunopositive 
cells at 100× using a high-numerical-aperture 
objective lens on a random fraction com-
prising 20% of every third section. Counted 
cells were then multiplied by 3 to obtain the 
crude cell count (CC). To correct for double 
counting of a single nucleus found in two 
sections, we used the Abercrombie formula 
(Abercrombie 1946):
  TC = (CC × S)/(S + D), 
where TC is the corrected number of labeled 
cells per testis, S is the thickness of the sections 
(5 µm), and D is the average diameter of the 
nuclei of labeled cells, obtained by division of 
the mean nuclear diameter defined on sections 
by π/4 (Lassurguere et al. 2003). All counts 
and measurements were performed blind to 
treatment conditions.
Figure 1. Effect of DEHP and MEHP on testicular histology (A–D) and the total number of gonocytes (E) after 
72 hr of culture beginning on GD14.5 (see “Materials and Methods” for experimental details). (A) Histology of 
non  exposed (control) fetal testis. (B, C, D) Effect of 10–6 M (B), 10–5 M (C), or 10–4 M (D) MEHP on the histology 
of seminiferous tubules in fetal rat testes after 72 hr in culture. Gonocytes were immunostained with DDX4/
VASA antibody, revealed by AEC (red), and Leydig cells were immunostained with 3β-HSD antibody, revealed 
by DAB (brown). Scale in (A) also applies to (B–D). Arrows in (B) and (C) indicate holes and degenerative 
gonocytes within seminiferous tubules. In (D), seminiferous tubules were not recognizable. (E) Effect of DEHP 
and MEHP on the total number of gonocytes. Responses to DEHP and MEHP were meas  ured by comparing 
one control testis (DMSO-treated) with the contra  lateral testis cultured in medium containing the tested fac-
tor. Values are mean ± SE of 3–7 fetuses in at least two independent experiments. The numbers in parenthe-
ses indicate the percent decrease relative to the corresponding control.
*p < 0.05, and **p < 0.01 by Wilcoxon signed rank tests performed on paired data.
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Gonocyte apoptotic and mitotic indexes. 
For apoptotic cell staining, we performed ter-
minal deoxynucleotidyl transferase-mediated 
2´-deoxyuridine 5´-triphosphate nick end 
labeling (TUNEL) assays (In Situ Cell Death 
Detection Kit, POD; Roche Diagnostics, 
Meylan, France) following a method previ-
ously described by Lassurguere et al. (2003) 
and Livera et al. (2000). Briefly, sections were 
deparaffinized, rehydrated, and pretreated by 
microwave boiling in 0.01 M citrate buffer. 
After washing in PBS, endogenous peroxidase 
was quenched in 3% hydrogen peroxide/PBS 
buffer. DNA fragmented in apoptotic cells 
was labeled by enzymatic incorporation of 
fluorescein-12-dUTP (Boehringer Ingelheim, 
Paris, France) at the free 3´ OH-termini of 
the DNA fragments and exposed to anti-
fluorescein antibody conjugated to peroxidase 
(Boehringer Ingelheim). The apoptotic cells 
were then revealed by DAB. To restrict the 
counting of the TUNEL-positive gonocytes, 
the sections were secondarily incubated with 
a DDX4/VASA antibody (Abcam), visualized 
by AEC (Beckman Coulter), and counter-
stained and mounted.
We defined a mitotic index by adding 
50 µM BrdU (Abcam) to media during the 
3 hr before fixation (Lassurguere et al. 2003). 
BrdU-positive cells were detected by immuno-
histo  chemistry. Sections were deparaffinized, 
rehydrated, and microwave-cooked for 5 min 
in 0.01 M citrate buffer (pH 6.0). After wash-
ing in PBS, slides were incubated successively in 
3% H2O2/PBS for 15 min, in 2N HCl at 37°C 
for 20 min, and in 0.07 M NaOH for 10 min. 
Sections were then rinsed in PBS and incu-
bated overnight with anti-BrdU monoclonal 
antibody (DAKO). We detected the antibody 
using a peroxidase-linked anti-mouse IgG cell 
proliferation kit (Amersham, Les Ulis, France) 
followed by incubation with streptavidin-HRP 
and finally visualization with DAB. The BrdU 
incorporation index was defined by counting 
at least 500 gonocytes specifically recog  nized by 
immuno  staining with the DDX4/VASA anti-
body visualized with AEC, as described above.
Testosterone assay. The medium of each 
culture was recovered every 24 hr and stored 
at –80°C until a testosterone radio  immuno-
assay could be performed (Testosterone 
Direct RIA kit; Beckman Coulter, Villepinte, 
France). Each sample was assayed in dupli-
cate, without prior extraction. 
AMH assay. We used an AMH enzyme-
linked immunosorbent assay (ELISA) 
kit (DSL-10-14400; Diagnostic Systems 
Laboratories Inc., Cergy Pontoise, France) 
according to the manufacturer’s instructions 
to determine the AMH level secreted by testes 
in the media. Each sample (20 µL of daily half-
medium recovered) was assayed in duplicate, 
without prior extraction; the limit of detection 
was 0.006 ng/mL.
Statistical analysis. Wilcoxon signed rank 
and Wilcoxon Mann-Whitney tests were per-
formed on paired and unpaired data, respec-
tively, for the two-sample tests. We used 
non  parametric analysis of variance (ANOVA) 
for the dose–response experiments. We 
used SAS/STAT software (version 9.1; SAS 
Institute Inc., Cary, NC, USA) to perform all 
statistical analyses.
Results
MEHP decreases gonocyte number. The gross 
morphology of seminiferous tubules was dis-
turbed after treatment with 10–6 M, 10–5 M, 
and 10–4 M MEHP (Figure 1A–D) but not 
with DEHP (data not shown). At 10–4 M 
MEHP, we saw a global disorganization of the 
testis morphology (Figure 1D). The staining 
intensity of DDX4/VASA immuno  labeling of 
gonocytes in itself did not appear to be affected 
by MEHP. However, total numbers of gono-
cytes in MEHP-exposed testes were signifi-
cantly reduced in a time- and dose-dependent 
manner (Figure 1E).
MEHP induces a decrease of gonocyte 
mitotic index and an increase of gonocyte 
apoptosis. When cultured in the presence of 
10–5 M MEHP, the percentage of BrdU-
labeled gonocytes started to decline (–23%) 
at 48 hr and had significantly decreased 
(–36%) at 72 hr (Figure 2A). Furthermore, 
the number of apoptotic gonocytes in cultures 
treated with 10–5 M MEHP, as revealed by 
counting TUNEL-positive cells, was increased 
by factors of 1.5 and 1.6 at 48 hr and 72 hr, 
respectively (Figure 2B).
MEHP disrupts Sertoli cell function but 
has no effect on Sertoli cell number. Neither 
DEHP nor MEHP altered the total number of 
Sertoli cells (Figure 3D), and nuclei diameter 
was unchanged (mean ± SE diameter: con-
trol, 6.41 ± 0.22 µm; DEHP, 6.45 ± 0.20 µm; 
MEHP = 6.49 ± 0.18 µm; n = 30). However, 
10–5 M MEHP exposure produced Sertoli cell 
foci within the seminiferous cords (Figure 3C, 
arrowheads), and some appeared vacuolated 
(Figure 3C, arrows); this was not observed 
after DEHP exposure (Figure 3B). When we 
used immunohistochemistry to assess AMH 
expression in situ, we observed no differences 
in the labeling of the Sertoli cells (data not 
shown). Despite this, at 10–5 M, MEHP did 
inhibit AMH production at 48 hr (–72%; 
Figure 4). We observed a dose-dependent 
inhibitory effect of MEHP at 72 hr, with no 
effect at 10–6 M, but inhibition of 53% and 
81% at 10–5 M and 10–4 M, respectively. 
We observed a time-dependent increase of 
AMH production between 24 and 72 hr of 
culture (Figure 4). These pheno  types were all 
MEHP specific, with no effects occurring with 
DEHP treatment.
Figure 2. Effect of 10–5 M MEHP on the mitotic index and apoptosis of gonocytes. (A) Quantitative 
analysis of BrdU incorporation into gonocytes at 48 and 72 hr of culture measured as the percentage of 
BrdU-positive gonocytes in at least 500 cells (n = 4 fetuses at each time point). (B) Quantitative analysis 
of apoptotic gonocytes measured as the percentage of TUNEL-positive gonocytes in at least 500 cells 
(n = 4 fetuses at 48 hr and n = 6 fetuses at 72 hr). The numbers in parentheses indicate the percent 
decrease (A) or the factor of increase (B) relative to the corresponding control.
*p < 0.05 by Wilcoxon signed rank tests on paired data. 
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DEHP and MEHP have no effect on 
Leydig cell number. Neither DEHP nor 
MEHP had any effect on 3β-HSD staining 
intensity (Figure 5A–C), Leydig cell num-
ber (Figure 5D), or the Leydig cell nuclear 
diameter (control, 5.51 ± 0.16 µm; DEHP, 
5.54 ± 0.17 µm; MEHP, 5.28 ± 0.11 µm; 
n = 30). However, we consistently observed a 
number of cells marked by 3β-HSD–positive 
staining as Leydig cells within seminiferous 
tubules in MEHP-exposed gonads (Figure 5C, 
arrows).
DEHP stimulates testosterone produc-
tion, whereas MEHP inhibits it. A progressive 
increase in testosterone production was typical 
of the testis organoculture (Figures 6A, 7A). 
In the presence of 10–5 M MEHP, testos-
terone production was slightly but signifi-
cantly decreased (–14%) at 24 hr (Figure 6A). 
From 48 hr of culture onward, 10–5 M 
MEHP prevented the age-related increase 
in testosterone production (Figure 6A). The 
MEHP-decreased testosterone production 
corresponded to 42% at 48 hr (Figure 6A). 
By 72 hr, although 10–5 M DEHP slightly 
increased testosterone levels (p < 0.05), expo-
sure to 10–5 M MEHP significantly decreased 
these levels by 45% (Figure 6A). In another 
series of experiments, we confirmed the stim-
ulation of testosterone by DEHP at 72 hr 
(Figure 6B). Furthermore, we observed a 
dose-dependent decrease in testosterone pro-
duction using MEHP, with the lower concen-
tration (10–6 M) reducing the hormone levels 
by 21% (Figure 6B). When basal testosterone 
production was assessed in successive 3-hr 
time periods (24–27 hr, 48–51 hr, 72–75 hr) 
instead of the 24-hr time periods, as presented 
in Figure 6A and B, we always observed an 
inhibitory effect of 10–5 M MEHP on basal 
testosterone levels, although this inhibition 
was significant only for the 72–75 hr time 
period (p < 0.02 at 72–75 hr vs. p < 0.06 at 
earlier times; Figure 7A). The presence of LH 
in the culture media revealed an increased 
ability of the fetal gonad to secrete testoster-
one along the culture period. Interestingly, 
the fetal gonad also appeared to respond to 
LH in terms of testosterone production as 
early as 48 hr (p < 0.05; Figure 7A). In the 
presence of 10–5 M MEHP, the LH-induced 
testosterone levels were always lower 
(p < 0.06 at 27 and 51 hr; p < 0.001 at 75 hr; 
Figure 7A). Although data in Figure 7B con-
firm the inhibitory effects of MEHP on basal 
and LH-induced testosterone production 
described above (Figure 6B), we also found 
a dose–response relationship in the MEHP 
inhibition of testosterone. This MEHP-
induced decrease in testosterone production 
was partially reversible, as shown by passage 
to phthalate-free medium (data not shown). 
Also, methyl palmitate at concentrations up 
to 10–4 M had no effect on testosterone lev-
els (data not shown), which indicates that 
the phthalate-induced effects of MEHP most 
likely did not result from the intrinsic lipo-
philic nature of these compounds.
Effects of MEHP and its oxidized metabo-
lites. At 10–5 M, MEHP and 5OH-MEHP 
significantly decreased gonocyte number by 
39% and 24%, respectively. Furthermore, 
basal testosterone production was decreased 
by 44% (p < 0.001) and 25%, respectively, 
after treatment with MEHP or 5OH-MEHP 
(Figure 8A,B). In contrast, neither 5OXO-
MEHP nor 5CX-MEHP produced such dele-
terious effects (Figure 8A).
Figure 5. Effect of DEHP and MEHP on the location (A–C) and number (D) of Leydig cells after 72 hr of 
culture beginning on GD14.5 (see “Materials and Methods” for experimental details). Con, Control. (A–C) 
Leydig cells were immuno  stained with 3β-HSD antibody and revealed by AEC (red) after treatment with 
control (A), 10–5 M DEHP (B) or 10–5 M MEHP (C). After MEHP exposure, we observed a low but consistent 
number of Leydig cells abnormally located within the seminiferous tubules (C, arrows). The scale in (A) 
also applies to (B–C). (D) Leydig cells were counted using systematic random sampling accomplished 
by the CAST-grid stereotaxic system. Values are mean ± SE of 4 fetuses from at least two independent 
experiments. No significant difference in number was found using Wilcoxon signed rank tests. 
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Discussion
Based on a search of PubMed (U.S. National 
Library of Medicine, Bethesda, MD, USA) 
using the terms “phthalate” and “testis,” 
we found that < 11% of the approximately 
300 references used in vitro experimental 
approaches. However, using an in vitro system 
to study the effects of phthalates on the fetal 
testis has a number of important advantages. 
In particular, it is possible to investigate direct 
effects of these compounds using controlled 
concentrations. The kinetics of action and 
primary cellular target(s) within the gonads 
are more easily determined using an in vitro 
approach, and they validate its use in addi-
tion to, or in place of, the classical in utero 
approach.
In the present study we used a rat organo-
typic culture system that supports normal 
differentiation of the fetal gonad during at 
least 3 days (Livera et al. 2006). Although this 
system has previously been validated for toxi-
cology purposes using estradiol and diethyl-
stil  bestrol (Lassurguere et al. 2003), at first 
we were unable to see any effect of DEHP or 
MEHP (data not shown). These results were 
in agreement with similar attempts to use this 
system (Hallmark et al. 2007; Li and Kim 
2003; Stroheker et al. 2005). However, when 
we modified the culture conditions by chang-
ing half of the culture media daily instead 
of a complete daily change/replacement 
(Lassurguere et al. 2003), we then observed a 
number of direct phthalate-induced effects on 
the cultured fetal gonad. 
In another series of experiments, we deter-
mined that DEHP is not metabolized under 
our culture conditions (data not shown). This 
indicates that, between GD14.5 and GD17.5, 
the rat fetal gonad does not express the esterase 
and cytochrome P450 enzyme systems that are 
involved in the metabolism of phthalate esters. 
Furthermore, this also indicates that the effects 
of these compounds reported in the present 
study were most likely due to the compound 
tested rather than metabo  lites. In the in utero 
experiments reported by Stroheker et al. 
(2006), most of the DEHP was metabolized, 
and only a very small proportion of it (2–5%) 
was able to cross the placental barrier and be 
detected in the GD18 fetal testis. A central 
observation of our in vitro study is that DEHP 
caused no deleterious effects. This finding is 
compatible with previous experiments estab-
lishing that MEHP is the active metabolite of 
DEHP and is involved in the testicular disrup-
tion observed in utero (Foster et al. 2001).
We found that 10–4 M MEHP reduced 
testosterone levels to the threshold of detection 
and disorganized the testis to such a degree 
that cell counting was impossible. This is why 
we chose to perform more experiments using 
the 10–5 M concentration. This level allowed 
us to explore the sequence of action of MEHP 
on different cell types. By tracking 14C-DEHP 
and 14C-MEHP in different compartments 
of our culture systems, we determined that 
at 10–5 M, only 0.3–0.4% of these two 
phthalates were present in the testicular fetal 
explants under our culture conditions, which 
corresponded to a concentration of about 
2,500 µg/L. Because of this and because we 
consistently saw anti  androgenic effects with the 
lower dose of MEHP (10–6 M), we consider 
the active concentrations of MEHP found in 
our study to be within an order of magnitude 
of the concentrations found in recent studies 
in the plasma from pregnant women [1,150 µg 
DEHP/L and 680 µg MEHP/L (Latini et al. 
2003)] or in neonate cord blood [2,050 µg 
DEHP/L and 520 µg/L MEHP (Latini et al. 
2003)].
At 10–5 M MEHP, we observed mis-
localization of Leydig cells within the semi-
niferous tubules, between the Sertoli cells. 
This finding matches in utero studies in the 
rat (Fisher et al. 2003; Mahood et al. 2006). 
Although the total number of Leydig cells did 
Figure 7. Time course (A) and dose response (B) showing effects of MEHP and DEHP on basal and 
LH-stimulated testosterone secretion by fetal rat testes cultured beginning on GD14.5. (A) For the time 
course, one testis from each fetus was cultured for 27, 51, or 75 hr in control medium or in medium con-
taining MEHP, with media changed every 24 hr. For the last 3 hr of the culture period, medium was supple-
mented with (+LH) or without (–LH) 100 ng/mL LH (24–27 hr, 48–51 hr, and 72–75 hr). (B) Effects of 10–5 M 
DEHP and increasing concentrations of MEHP on basal and LH-stimulated testosterone production after 
72 hr of culture. In this case, the control and phthalate-exposed testes did not originate from the same 
fetuses; the testes of different fetuses and from different mothers were assigned at random. In (A), values 
are mean ± SE of 6–18 fetuses from at least two independent experiments; in (B), values are mean ± SE of 
3–10 testes from at least two independent experiments. The values in parentheses indicate the percentage 
of decrease (–) or increase (+) relative to control.
*p < 0.05; and **p < 0.01 by Wilcoxon signed rank tests on paired data in (A) and nonparametric ANOVA on unpaired data 
in (B). ND, not detectable. 
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not vary, basal Leydig cell testosterone pro-
duction appeared markedly reduced in the 
MEHP-exposed cultures in a time- and dose-
dependent manner. These findings suggest 
that the anti  androgenic properties displayed by 
certain phthalates administered in utero actu-
ally result from direct action on fetal Leydig 
cell biology. We also found LH-stimulated 
testosterone production to decrease in a time- 
and dose-dependent manner. However, the 
intrinsic relative amplitude of the response of 
Leydig cells to LH was unchanged by MEHP. 
This indicates that the anti  androgenic activ-
ity of MEHP occurs separately from Leydig 
cell receptivity to LH. Interestingly, the cul-
tured fetal gonads were responsive to LH from 
GD15.5 to GD16.5, which is compatible with 
earlier studies establishing that both the tran-
script for LH receptor and LH receptor itself 
were first detected by GD16.5 in situ (Majdic 
et al. 1998; Zhang et al. 1994). LH is nor-
mally expressed by the fetal pituitary only from 
GD16.5 and is not detected in serum before 
GD18 (El-Gehani et al. 1998; Migrenne et al. 
2001). Ultimately, this finding establishes the 
competence of the organo  culture system insofar 
as it supports responsiveness to LH and marks 
the beginning of LH responsiveness in rat tes-
tes. Interestingly, that the inhibition of testos-
terone levels induced by MEHP was not due 
to a non  specific cytotoxic effect was established 
not only by the careful morphologic assessment 
of our study (histologic examinations, Leydig 
cell counts), but also by our results showing 
that methyl palmitate, a compound known to 
have the same lipo  philic properties as phtha-
lates (Krop et al. 1997; Staples et al. 1997), 
had no effect on testosterone production in the 
fetal gonad assay.
Unexpectedly, DEHP increased testoster-
one production at a concentration of 10–5 M. 
This pro  androgenic ability of DEHP has rarely 
been reported. Inhalation of DEHP has been 
reported to stimulate testosterone produc-
tion in prepubertal rats in a time- and dose-
dependent manner (Kurahashi et al. 2005). 
Likewise, DEHP seems to exert a positive effect 
on hepatic steroidogenesis (Fan et al. 2003; 
Wong and Gill 2002). According to a number 
of studies in rats (Barlow et al. 2003; Lehmann 
et al. 2004; Plummer et al. 2007), some genes 
involved in cholesterol uptake, transport to 
mitochondrion, and steroido  genesis are down-
regulated after in utero administration of di-n-
butyl phthalate, another phthalate known to 
exert in utero effects similar to those of DEHP 
(Howdeshell et al. 2007). This indicates that 
the anti  androgenic effects of phthalates most 
probably result from their action at differ-
ent transcriptional levels downstream of the 
LH receptor. In humans, 75% of the DEHP 
ingested is metabolized and excreted in urine 
within 2 days (Koch et al. 2005), although 
the resulting metabolites clear at different 
rates: 5OH-MEHP and 5OXO-MEHP clear 
quickly, whereas 5CX-MEPP takes longer 
(Koch et al. 2005). In urine from children, 
Becker et al. (2004) found concentrations of 
5OH-MEHP and 5OXO-MEHP to be 8.0-
fold and 6.2-fold higher than those of MEHP. 
This suggests that fetuses may experience 
greater exposure to these metabolites than to 
MEHP itself. Of the five phthalate esters tested 
here, DEHP appeared pro  androgenic, whereas 
MEHP and, to a lesser extent, its first metabo-
lite, 5OH-MEHP, were anti  androgenic.
We found that MEHP reduced the total 
number of gonocytes as early as 48 hr in cul-
ture, but phthalate-induced gonocyte apopto-
sis has also been described in the rat in utero 
(Ferrara et al. 2006) and in humans in vitro 
(Lambrot et al. 2009). Our finding stands 
in contrast to those of Li and Kim (2003), 
as these authors saw no effect of 100 µM 
MEHP on the number of gonocytes in testes 
after 3 days of culture of GD13 and GD18 
rat testes. This could be due to differences in 
the age at which the gonads were collected 
and cultured [GD13–GD16 by Li and Kim 
(2003) vs. GD14.5–GD17.5 here], because 
the critical windows of sensitivity of the rat 
fetal testis to phthalate and to the classical anti-
androgen flutamide have been determined to 
be GD15–GD18 (Carruthers and Foster 2005) 
and GD15.5–GD17.5 (Welsh et al. 2008), 
respectively. We determined that the decrease 
in gonocyte number in MEHP-exposed testes 
resulted from a combination of decreased pro-
liferation and increased apoptosis. The mecha-
nism behind this decrease remains unknown. 
Other toxicants that decrease gonocyte num-
ber, such as flutamide (Mylchreest et al. 1999), 
which antagonizes androgen signaling, produce 
distinctly different phenotypes. In vitro analy-
ses of human fetal testes (obtained between 
7 and 12 weeks of gestation) have revealed no 
effect of MEHP on basal or LH-stimulated 
testosterone production (Lambrot et al. 
2009). Similarly, Hallmark et al (2007) did 
not observe any effect of 10–3 M monobu-
tyl phthalate on human fetal testes obtained 
between 15 and 20 weeks of gestation Whether 
this absence of MEHP effect on human testes 
reflects a difference between rat and human 
biology or simply that the 7- to 12-week or 
15- to 20-week windows do not correspond to 
the phthalates sensitive stage in humans in vitro 
remains to be elucidated.
Much remains to be elucidated to under-
stand the mechanism(s) by which MEHP 
induces both an increase in apoptosis and a 
decrease in proliferation rate for gonocytes. 
Multiple but complementary pathways could 
be involved. For instance, recent in vitro stud-
ies using cultured Sertoli cells showed that 
MEHP induces the expression by Sertoli cells 
of solubilized Fas ligand, which binds to Fas, 
a germ-cell surface receptor able to trigger 
germ cell apoptosis (Boekelheide et al. 1998; 
Giammona et al. 2002). Another report pro-
poses that gonocyte apoptosis may be directly 
induced by MEHP via the transcription of Fas 
ligand (Yao et al. 2007). Other pathways, such 
as the tumor necrosis factor-related apoptosis-
inducing ligand-related pathway (McKee et al. 
2006) and the nuclear factor κ-B pathway 
(Rasoulpour and Boekelheide 2005) could 
also be involved in MEHP-induced germ 
cell apoptosis. Further investigation will be 
required to determine which elements mediate 
the MEHP effect on the gonocytes and more 
generally on the testis.
In the present study, neither DEHP nor 
MEHP had any effect on Sertoli cell number. 
This result corroborates in utero studies show-
ing that Sertoli cell number is not affected in 
phthalate-exposed GD17 testes (Scott et al. 
2008). However, vacuolization of these cells 
after exposure to 10–5 M MEHP for 3 days is 
similar to the pheno  type previously reported 
by Borch et al. (2006) for GD20–GD21 rat 
testis exposed in utero to DEHP and other 
phthalates. Certainly Sertoli cell function was 
affected because MEHP inhibited AMH pro-
duction in a time- and dose-dependent man-
ner. AMH immuno  labeling in a similar study 
(Li and Kim 2003) was not affected by MEHP 
in fetal gonads exposed to the same phthalate 
concentration although, as noted above, those 
fetal gonads were explanted at a younger age 
than in the present study. Furthermore, when 
we undertook immuno  histo  chemical labeling 
of Sertoli cells with AMH antibody, we also 
were unable to observe quantitative variation 
of AMH levels owing to the poor sensitiv-
ity of that assay. Ultimately, with higher lev-
els of MEHP (10–4 M), Li and Kim (2003) 
observed a decrease in AMH labeling. This is 
the same concentration at which we observed 
an 81% decrease in AMH production and 
dramatically altered morphology of the tes-
tis. Lambrot et al. (2009) also recently found 
an MEHP-induced decrease in the mRNA 
expression of AMH by human fetal testis 
in vitro at 10–4 M. Whether the MEHP-
induced alteration of Sertoli cell morphology 
and function is mediated by effects on testos-
terone, a reduced gonocyte population, or a 
combination remains to be established.
In conclusion, our study demonstrates the 
facility of an in vitro system, the fetal gonad 
assay, as an effective assay for the effects of 
MEHP and other potential endocrine disrup-
tors. This alternative to in utero study eluci-
dates direct dose -and time-dependent effects 
of phthalates. Using this system, we found 
that deleterious effects of MEHP first occurred 
in Leydig cell function, followed by a con-
comitant decrease in the germ cell pool and in 
Sertoli cell function. Most important, we dem-
onstrated that the actual active dose of MEHP 
corresponds to a concentration within an order In vitro phthalate effects on fetal rat testis
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of magnitude of the phthalate concentrations 
found in human biological fluids. We are now 
using the fetal gonad assay to investigate the 
precise mechanisms by which MEHP disrupts 
steroidogenesis.
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